Translational Research
For the birth of something
new, there has to be a happening. Newton saw an apple fall; James Watt watched
a kettle boil; Roentgen fogged some photographic plates. And these people knew
enough to translate ordinary happenings into something new- Alexander
Fleming
Translation is to convert practical into
practice. Translational research is the research process that investigates and
translates nonclinical research results into clinical applications and tests
their safety and efficacy in a Phase 1 clinical trial. It is aimed at translating (converting) results of basic
research into results that directly benefit humans.
Translational research involves the application of knowledge gained through basic research to studies that could support the development of new products. For example, translational research in the field of medicine may involve using knowledge of the biology of a disease to identify and evaluate chemical compounds in disease models, with a view to selecting potential candidate drugs to advance into clinical trials.
The primary goal of “translational” research is to integrate
advancements in molecular biology with clinical trials, taking research from
the “bench-to-bedside”
The 2-tier model of Translational
research has layers namely, T1 research which refers to the
"bench-to-bedside" enterprise of translating knowledge from the basic
sciences into the development of new treatments and T2 research
which refers to translating the findings from clinical trials into everyday
practice.
Latest classification includes
5 stages: T0- T4.
ü T0 stage is associated with laboratory (in-vitro and in-vivo) research. It includes target identification,
hit-to-lead identification, lead optimization and pre-clinical studies.
ü T1 stage: It is associated with new laboratory discoveries that
are translated to human application including phase I clinical trials.
ü T2 Stage: It includes candidate applications progressing
through clinical development to generate the evidence for integration into
clinical practice guidelines. This includes phase II and III clinical trials.
ü T3 stage: It includes broadcasting of research and outcomes
of earlier stages into community practice.
ü T4 stage: T4 translation seeks to advance scientific knowledge to paradigms of disease prevention and health practices established in T3 into population health impact.
Translational
research:
ü Encourages and promotes
multidisciplinary collaboration among laboratory and clinical researchers.
ü Incorporates the desires of the public
with communities being engaged to determine their needs for health innovation.
ü Identifies and supports the adoption
of best medical and health practices.
Dabur Research Foundation
(DRF) has extensive knowledge and experience in translational research of
Synthetic & botanical leads. At DRF, we work extensively on Stage T0 and
hold capabilities to take our collaborators through later stages. We have
different departments to assist in different phases of Stage 0 (bench to
bedside) research:
ü Formulation Department
ü Cell Biology Department (in-vitro
studies)
ü Pharmacology Department (in-vivo
studies)
ü Analytical Department
ü Toxicology Department
ü Genotoxicity Department
All the departments work in
co-ordination with each other to provide end to end preclinical services to
address all your requirements and enable successful translational research.
Success Stories of DRF in
Translational Research:
ü Extensive
preclinical studies to determine the complete mechanism of uptake, delivery and
action of Nanoxel in cancer cells.
ü Complete
preclinical testing of efficacy, safety studies for products in dermal
pathologies such as psoriasis, eczema and acne. Products have been tested in
multiple clinical trials.
ü Preclinical
testing for hair growth promoting ability of a product in animal model of
telogen to anagen transition. Product is now in Phase-2 clinical trial.
ü Preclinical
testing for anti-aging, hair growth promotion and anti-osteoarthritic activity of
Stem cell-based products. Products have been successfully launched in market.
ü Preclinical
studies with Herbal mixtures in the areas of Wound healing, Hirsutism and Erectile
dysfunction.
ü Preclinical
studies with Herbal mixtures in the areas of diabetes, cataract, bone health, skin
health, hair growth, antimicrobials, liver health.
ü Preclinical
studies with Herbal mixtures in the areas of anti-lice, anti-tick, anti-fungal activities.
Anti-lice product has been tested in clinical trial.
Comments
Post a Comment